Statin use linked to risk of skin and soft tissue infections
Use of statins was associated with increased risk of SSTIs at an average of 91, 182, and 365 days.
Rivaroxaban trends toward higher thrombotic risk than vitamin K antagonists in APS
Patients who took rivaroxaban experienced almost two times as many thrombotic events as patients who took dose-adjusted vitamin K antagonists.
HHS floats Stark/anti-kickback revisions to support value-based care
Health law attorneys say reforms should remove some of the risk in value-based care arrangements that exist under current law.
* * *
Card Talk:
Cardiologist brothers Jim and Jerry Dwyer welcome Jennifer N. Avari Silva, MD, and Berk Tas, to talk about an investigational system for electrophysiology procedures that displays holograms of patients’ anatomies in real time. The SentiAR system uses an augmented-reality head-mounted display that allows physicians to manipulate the data and enhance their understanding of the case.
Dr. Avari Silva, MD, is assistant professor of pediatrics at Washington University in St. Louis and director of pediatric cardiac electrophysiology at St. Louis Children’s Hospital, where she leads the largest pediatric electrophysiology program in the midwest. Dr. Avari Silva has published numerous papers bringing new technologies to pediatric patients.
Berk Tas is CEO and president of SentiAR. He has led development of emerging technologies and companies in Fortune 500, private equity, venture capital funded and privately held organizations.
For more MDedge Podcasts, go to mdedge.com/podcasts
Email the show: podcasts@mdedge.com
Interact with us on Twitter: @MDedgeCardio
Top stories from the American Heart Association scientific sessions
Vascepa gains event-reduction nod; diabetes ups ischemic risks
Post-STEMI events less likely in women; bariatric surgery may lower stroke risk
New trick for old drug; Vascepa cost effective for CV reduction
Card Talk: TAVR and glass ceilings
ISCHEMIA trial, DAPA-HF, and valsartan recall: AHA Special
Long-awaited ISCHEMIA results to change practice, DAPA-HF elevates dapagliflozin for HFrEF
Pot heightens stroke, arrhythmia risks; keeping low LDL and BP slashes lifetime heart risk
How risk factors in childhood translate to CV outcomes in adulthood
Driving while defibrillating; hypertension holds greater risk in black patients
AFib hits Native Americans hard; TAVR shown durable, safe after 5 years
Practice changing prevention data from ESC 2019 Part II
Troponin protocol rapidly rules out MI; hidden risk of moderate aortic stenosis
Sun sets on longer DAPT after PCI; inactivity boosts post-MI risk
Cardiology dead last as women’s IM subspecialty choice
An antiplatelet surprise; Europeans go low in cholesterol guidelines
SGLT-2 inhibitors and more practice changing data from ESC 2019
Overweight BMI surpasses 'normal' and introducing the 'Card Talk' segment
Dapagliflozin transforms into heart failure drug
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive